None
Quote | Bicycle Therapeutics plc (NYSE:BCYC)
Last: | $ |
---|---|
Change Percent: | 6.99% |
Open: | $12.80 |
Close: | $13.32 |
High: | $13.60 |
Low: | $11.975 |
Volume: | 23,074 |
Last Trade Date Time: | 02/12/2020 04:41:42 pm |
News | Bicycle Therapeutics plc (NYSE:BCYC)
Bicycle Therapeutics plc (NASDAQ: BCYC), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle ® ) technology, today announced the acceptance of two abstracts for poster presentation at the 2024 Amer...
2024-04-03 07:26:26 ET More on Homology Medicines Financial information for Homology Medicines Read the full article on Seeking Alpha For further details see: Q32 Bio names Lee Kalowski as CFO
Message Board Posts | Bicycle Therapeutics plc (NYSE:BCYC)
Subject | By | Source | When |
---|---|---|---|
STRONG.......As the move back to where this stock | dhbuzz | investorshub | 08/08/2022 9:06:22 PM |
Good week,should continue gaining.Watching for another pharma .to | dhbuzz | investorshub | 08/06/2022 1:31:26 AM |
Lot of up side potential here at the | dhbuzz | investorshub | 07/20/2022 8:37:42 PM |
News, Short Squeeze, Breakout and More Instantly...
Bicycle Therapeutics plc Company Name:
BCYC Stock Symbol:
NYSE Market:
Bicycle Therapeutics plc (NASDAQ: BCYC), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle ® ) technology, today announced the acceptance of two abstracts for poster presentation at the 2024 Amer...
Bicycle Therapeutics plc (NASDAQ: BCYC), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle ® ) technology, today announced that management will participate in a fireside chat at the 23rd Annual N...
Bicycle Therapeutics plc (NASDAQ: BCYC), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle ® ) technology, today announced the acceptance of three abstracts for poster presentation at the America...